Remote Consultation Systems

RemetricHealth is a remote patient monitoring (RPM) and chronic care management provider serving physician groups, hospitals, home health agencies, community health centers, and payers across the United States. The company delivers real-time biometric and compliance monitoring combined with clinical nursing services to assess patients remotely between office visits. Core offerings include FDA-cleared wireless biometric devices (primarily blood pressure monitors, glucose meters, and weight scales), a HIPAA-compliant web portal and mobile applications for both healthcare staff and patients, and clinical support services performed by RemetricHealth's nursing staff. The platform provides real-time data visualization, trend reporting, and automated alerts for out-of-range readings. RemetricHealth specializes in monitoring chronic conditions including congestive heart failure (CHF), hypertension, chronic obstructive pulmonary disease (COPD), and diabetes. The company is FDA-registered and ISO 13485–certified, ensuring regulatory compliance for its devices, portals, and applications. RemetricHealth operates a nursing team that performs patient assessments, provides wellness checks, medication adjustment coordination, patient education, and responsive follow-up via phone, text, and email. The solution is designed to reduce unnecessary hospital admissions and emergency department visits while improving patient engagement and clinical outcomes. The platform integrates with existing healthcare workflows and supports CPT-based reimbursement models for RPM and chronic care management services.

Level 42 AI is a Silicon Valley-based digital health startup developing software-defined hardware and AI algorithms that capture and analyze multi-modal vibrational biosignatures from the human body to predict, detect, diagnose, and monitor health conditions. The company's Vibrome® biosignature platform analyzes infrasonic-to-ultrasonic vibrational data from the heart, lungs, and gut—traditionally unobserved signals—using proprietary machine learning to identify early disease markers and quantify health state from brief 5–30 second data snippets. Level 42 AI offers three product categories: Point-of-Care systems for urgent care and telemedicine triage; Point-of-Habitat integrated biometric furniture for continuous home monitoring; and Point-of-Person wearables (watches, earrings, bracelets, necklaces, shoes) for self-directed continuous health phenotyping. The company is conducting clinical validation studies with Johns Hopkins School of Medicine and UCSF for COVID-19 biosignatures, with applications spanning respiratory (asthma, COPD, cystic fibrosis, TB), cardiovascular (coronary artery disease, heart failure, carotid disease), and other chronic conditions. Services include non-invasive sensor fusion data capture, online patient health tracking, practice management software, and just-in-time wellness insights.

FondCircle is a digital health company providing smart, connected home health monitoring devices and a telehealth platform. The company offers a range of FDA-cleared or regulated medical devices including Bluetooth-enabled blood pressure monitors (upper arm and wrist), pulse oximeters, blood glucose meters, infrared thermometers, and smart body composition scales. All devices sync with the FondCircle mobile app (iOS/Android), enabling users to track health metrics, review trends, and share data with healthcare providers. The platform also facilitates practitioner listings and remote consultations. FondCircle targets consumers, families, and health systems seeking accessible, accurate at-home monitoring and hospital-level telehealth services without frequent clinic visits.

Parable Health is a mobile, computer vision-powered asynchronous telemedicine platform specializing in chronic woundcare management. The platform enables clinicians to measure, monitor, and manage complex patient populations through automated volumetric measurements, quantitative and qualitative assessments, and comprehensive risk scoring. Parable integrates with EHR systems and clinical IT infrastructure to automate complex workflows, standardize care protocols, and scale clinical expertise across broader patient populations. The platform leverages machine learning on millions of comprehensive wound assessments to deliver actionable clinical insights and reduces human error and variability in documentation. Parable supports both post-acute and inpatient wound management, as well as ambulatory follow-up scenarios including plastic surgery, orthopedics, and dermatology. The platform operates on familiar mobile devices with store-and-forward telemedicine capabilities, enabling remote collaboration and reducing excessive labor, transportation, and supply costs.

Biokinemetrics is a healthcare technology company delivering hospital-grade digital X-ray imaging systems, software platforms, and teleradiology services to independent medical practices, urgent care facilities, chiropractors, and veterinary clinics. The company specializes in space-efficient diagnostic imaging solutions designed for small-to-medium practices, offering integrated hardware and software packages that streamline clinical workflows, reduce operational complexity, and enhance diagnostic accuracy. Core offerings include ChiroSight (chiropractic imaging), VetSight (veterinary imaging), MedSight (medical practice imaging), and TeleRad (remote radiology consultation services). Biokinemetrics focuses on delivering equipment integration, comprehensive reporting tools, medical imaging system upgrades, warranty support, and tele-radiology services that enable practitioners to diagnose faster, manage operations more efficiently, and improve patient outcomes without requiring enterprise-scale infrastructure.

Welldoc is a digital health platform company specializing in AI-driven chronic disease management, with a focus on diabetes, hypertension, heart failure, obesity, and behavioral health. Founded in 2005 by an endocrinologist, Welldoc delivers clinically-validated, evidence-based solutions that integrate personalized, real-time insights into patient workflows. The flagship product, BlueStar® (FDA-cleared prescription digital therapeutic), provides automated patient coaching and real-time guidance for adults with type 2 diabetes. Welldoc's platform enables "care anywhere" delivery models for health plans, healthcare systems, and employers, integrating disparate health data into actionable clinical insights across the cardiometabolic spectrum. The company collaborates with major partners including Abbott, CVS Health, Eli Lilly, Dexcom, and others, leveraging data science and behavioral algorithms to improve medication adherence, lifestyle change, and self-management outcomes.

International Medical Solutions (IMS) is a software and services company specializing in cloud-native medical imaging platforms for diagnostic and educational applications. IMS develops DICOM-compliant viewing solutions built on HTML5 and cloud infrastructure (Google Cloud, Microsoft Azure) that enable healthcare clinicians, radiologists, and researchers to securely view, annotate, and share medical imaging data remotely without local installation or infrastructure overhead. Core offerings include IMS CloudVue (native cloud-based DICOM viewer with real-time performance), IMS CloudSync (cloud storage and synchronization with intelligent caching for offline/online workflows), and IMS Learn (web-based educational platform for creating interactive quizzes and training sessions with full-resolution medical images). The company maintains FDA, Health Canada, and ISO compliance with emphasis on data security, disaster recovery, and business continuity. IMS partners with academic medical centers, health systems, and radiology organizations globally.

Computational Diagnostics, Inc. (CDI) is a manufacturer of clinical neurophysiology systems and provider of intraoperative neurophysiological monitoring (IOM/IONM) services. Founded in 1988, CDI develops and operates multi-modality neurophysiologic monitoring equipment designed to protect neural structures during surgical procedures. The company's flagship NeuroNet® platform enables real-time neurophysiological data acquisition and remote interpretation by attending neurophysiologists, allowing surgeons to monitor nervous system integrity during complex procedures. CDI offers turnkey IOM services with nationally certified neurotechnologists and neurophysiologists collaborating to deliver immediate clinical feedback. The company also develops telemedicine and home-use neurophysiology systems, supported by research funding from the Army's Telemedicine and Advanced Technology Research Center and the National Institute of Neurological Diseases and Stroke. CDI's technology has received recognition including Computer World/Smithsonian awards.

Caregility Corporation is an enterprise telehealth and virtual care platform provider serving healthcare systems, hospitals, and care facilities across inpatient, outpatient, and home settings. Founded in 2011, the company delivers the Caregility Connected Care™ Platform, a cloud-based ecosystem that integrates AI-powered clinical workflows, virtual nursing, bedside sensors, and secure video collaboration tools. The platform enables virtual care delivery across emergency departments, ICUs, operating rooms, observation units, behavioral health, neonatal care, and long-term care environments. With deployments in over 1,100 hospitals across 85+ health systems, Caregility facilitates more than 6 million virtual sessions annually. The platform addresses critical healthcare challenges including clinician shortages, geographic access barriers, and operational inefficiency through features such as real-time clinical collaboration, remote patient monitoring, automated workflow support, and integrated analytics. Caregility emphasizes 99.99% platform availability, HIPAA compliance, ISO 27001/27701 certification, and 24/7 expert support, positioning itself as a mission-critical infrastructure provider for hospital networks seeking to scale virtual care at enterprise scale.

TytoCare is an AI-powered remote physical examination platform that enables clinicians to conduct comprehensive diagnostic exams from any location—home or community site. The company's Smart Clinic solutions include FDA-cleared hardware (digital stethoscopes, examination cameras) and advanced diagnostic software that replicates in-person clinical assessments for heart, lungs, throat, ears, skin, abdomen, and vital signs (temperature, heart rate). TytoCare serves 240+ healthcare organizations, 1.6M+ patients, and 40K+ providers globally, with deep integrations across health systems, health plans, and Medicaid programs. The platform features FDA-cleared AI algorithms for detection of pulmonary abnormalities (wheeze, rhonchi, crackles) and clinical decision support. Two primary offerings: Home Smart Clinic for patient self-exams with remote clinician supervision, and Pro Smart Clinic for field-based clinician-conducted exams. Clinical evidence demonstrates 6X higher utilization versus traditional telehealth, 98% remote resolution rate, 8.5% total cost-of-care reduction, and 83 NPS score. Trusted by Corewell Health, Sanford Health, Clalit, Elevance, Presbyterian, and major U.S. health systems.

Cloudphysician is an AI-driven healthcare technology company providing AI-powered Smart-ICU solutions and virtual critical care services. Founded in 2017 by critical care physicians, the company operates the proprietary RADAR platform—an ambient intelligence system integrating high-definition video, computer vision, AI analytics, and electronic medical record data to enable 24/7 remote ICU monitoring and clinical decision support. The platform detects and prevents adverse events including inpatient falls, pressure ulcers, central line infections, and catheter-associated UTIs, reducing hospital-acquired complications and associated costs. Cloudphysician has deployed solutions across 280+ hospitals managing 2,000+ ICU beds across 22 Indian states, serving 130,000+ patients. The company offers disease-specific AI agents, real-time video analysis, virtual nursing capabilities, and Smart-ICU in a Box solutions optimized for both urban and rural healthcare settings. Its hardware-agnostic architecture integrates seamlessly with existing hospital infrastructure (monitors, cameras, tablets) without requiring device upgrades. The platform operates securely on-premise or in cloud environments with full HIPAA, SOC 2, and ISO 27001 compliance, ensuring patient data remains within hospital environments with no external data transfer.

TympaHealth Technologies Ltd is a digital health company specializing in comprehensive ear and hearing health solutions. Founded by ENT surgeon Dr. Krishan Ramdoo, the company combines clinical expertise with proprietary technology to deliver point-of-care assessments across NHS Trusts, private audiology practices, pharmacies, and care homes. The TympaHealth platform features HD digital otoscopy for high-definition ear canal and eardrum imaging, automated 4-frequency hearing checks (500Hz–4kHz), microsuction-based cerumen removal, and secure cloud-based digital patient records. The system integrates specialist referral pathways for complex cases requiring ENT oversight. TympaHealth is fully NHS and GDPR compliant, HIPAA and DTAC certified, and processes over 40,000 patient appointments monthly. The company has served 250,000+ patients and operates a scalable community pharmacy model for ear and hearing health checks. Services include continuous practitioner support, specialist-led training accredited by ENT and audiology experts, and clinical governance oversight to ensure safe, high-quality care delivery.

Kinex Medical Company is a Wisconsin-based manufacturer of durable medical equipment (DME) specializing in orthopedic rehabilitation and post-surgical recovery. The company serves acute, post-acute, and home-based rehabilitation markets with a comprehensive product portfolio including continuous passive motion (CPM) devices, cold therapy systems, electrotherapy/TENS units, compression garments, bracing solutions, and joint contracture management equipment. Kinex offers the KinexCONNECT telerehabilitation platform, which provides real-time patient monitoring and compliance tracking to optimize outcomes for total knee replacement and other orthopedic procedures. The company also supplies mastectomy products, DVT prophylaxis compression therapy devices, and related billing and delivery services. With 444 employees and $65.3M in annual revenue, Kinex serves hospitals, ambulatory surgery centers, and healthcare organizations seeking integrated in-home rehabilitation solutions.

Veris Health is a digital health platform specializing in personalized cancer care through remote patient monitoring and clinical connectivity. As a majority-owned subsidiary of PAVmed Inc., the company delivers the Veris Cancer Care Platform—a cloud-based solution enabling continuous bidirectional communication between patients and oncology care teams. The platform integrates physiological data collection via VerisBox™ connected devices, symptom tracking, secure messaging, and scheduled video consultations with EHR interoperability. Features include real-time trend analysis, quality-of-life assessments using EQ-5D™, automated reimbursement documentation, and family/caregiver engagement tools. Available on iOS and Android with Spanish-language support. The platform is HIPAA and SOC compliant and aligns with value-based care models including CMS's Enhancing Oncology Model (EOM). Designed for oncology practices, hospital systems, and cancer centers seeking to improve patient engagement and clinical outcomes through remote monitoring.

ixlayer is a cloud-based, direct-to-patient platform serving biopharma, health systems, and clinical labs with integrated precision health testing, remote diagnostics, and virtual care solutions. The unified platform streamlines patient journeys across the healthcare ecosystem, enabling at-home diagnostic testing, telehealth integration, prescription fulfillment, benefits verification, and medication management. ixlayer supports clinical onboarding, patient intake, consent workflows, and provider connectivity through partnerships with leading telehealth and pharmacy networks. The platform has powered over 1,100 programs and facilitated more than 4 million patient care journeys, demonstrating significant impact on diagnostic compliance (+70% vs. U.S. benchmark), patient activation (+2.5x), and care access. Designed for rapid deployment and scalability, ixlayer enables biopharma brands to launch customizable programs across multiple therapeutic areas while maintaining compliance with CLIA and laboratory-developed test regulations.

Foresight Imaging is an OEM manufacturer of high-performance video capture boards and PACS connectivity solutions for medical and defense imaging applications. ISO 13485 certified, the company has produced over 100,000 imaging boards in use at elite medical centers worldwide. Foresight Imaging specializes in high-accuracy video streamers and frame grabbers supporting multiple video signal types (HDMI, DVI, SDI, monochrome, RGB, analog, standard and non-standard formats) with sustained transfer rates up to 1.3 GB/second and advanced signal processing (±0.5 ns pixel jitter, 59 dB signal-to-noise ratio, 10-bit A/D conversion). The company's TIMS platform is a 510(k)-accredited analog-to-DICOM workstation solution combining image acquisition software with telemedicine capabilities for remote diagnostics. Applications include surgical recording, angiography, OCT, ultrasound imaging, and specialized medical visualization. Foresight provides comprehensive OEM support including software development kits (C libraries, DirectShow drivers, example programs in .NET, C++, Linux), technical engineering support during development, and automated configuration tools.

OKKO Health is a UK-based healthcare software company specializing in smartphone-based home vision monitoring for chronic eye diseases, particularly age-related macular degeneration (AMD). The platform operates as a concierge service between clinic appointments, enabling patients to self-monitor vision through engaging puzzle games that embed vision science without requiring external hardware. The system provides clinicians with data-driven insights for disease management, supports early detection of vision changes, and facilitates urgent fast-tracked review when indicated. OKKO Health's offering complements long-acting therapy scheduling, serves as a safety net between appointments, and qualifies for remote patient monitoring reimbursement. The company has expanded to the U.S. market and partners with Topcon Healthcare to advance personalized eye care and vision data diversity for research applications.

Biotricity Inc. is a publicly traded medical technology company (NASDAQ-listed, 2021) specializing in remote cardiac monitoring and chronic disease management solutions. Founded in 2010 and headquartered in Redwood City, California, the company develops FDA-cleared wearable cardiac monitoring devices and cloud-based platforms for continuous biometric data collection and analysis. Biotricity's product portfolio includes Bioflux® (mobile cardiac telemetry), Biocore (3-channel ECG Holter monitor with 30-day recording), Bioheart (consumer-grade continuous heart rate monitoring), Biokit (multi-vital remote patient monitoring kit), and Biocare (chronic disease management platform). The company operates a dual-revenue model combining recurring Technology-as-a-Service (TaaS) monitoring fees with device hardware sales. Biotricity serves both clinical providers and direct-to-consumer markets, with trusted monitoring for over 100,000+ patients. The platform emphasizes faster diagnosis (3-5 days vs. 2-3 weeks), wireless data transmission via Bluetooth, and physician-reviewed analysis by cardiologists. Biotricity addresses the growing demand for telehealth and proactive cardiac care management, reducing patient risk and improving clinical outcomes.

IONIC Health is a health-tech company specializing in automation and integration technologies for diagnostic medicine and healthcare delivery. The company provides remote operations platforms, monitoring and management software, and AI-powered reporting solutions for imaging devices and clinical workflows. IONIC Health serves healthcare providers worldwide with solutions for teleradiology, equipment teleoperation, sensor data analytics, and structured medical report generation. The platform supports 300+ devices in remote teleoperation, monitors 50,000+ healthcare equipment units, and has processed over 1 million medical reports. The company also offers consulting services for digital transformation, process optimization, cost reduction (5-15%), and big data analytics in diagnostic medicine. With 90+ B2B clients including major healthcare networks, 110+ employees across 4 countries, and partnerships with leading diagnostic imaging centers, IONIC Health enables efficiency gains and expanded access to diagnostic services through cloud-based automation.

CEIBA Health Technologies is an AI-powered healthcare technology platform specializing in virtual clinical care and medical device connectivity solutions. The company delivers an integrated Enterprise Suite with four core capabilities: (1) IoMT Interoperability—featuring a plug-and-play IoMT Box with 1,000+ pre-installed device drivers supporting 20+ EHR integrations; (2) Continuous Monitoring—delivering real-time telemetry dashboards for patient monitors, ventilators, infusion pumps, blood gas analyzers, and EEG machines across ICU, med-surge, LTACH, and SNF settings; (3) Decision Support & Workflow—providing actionable clinical insights and operational dashboards; and (4) Virtual Clinical Care—a telehealth platform enabling multi-specialty consultations, remote rounding, and acute care at home. CEIBA's protocol-agnostic architecture supports HL7, FHIR, JSON, and XML with enterprise-grade security, encrypted data transfer, and full mobile functionality. The platform is designed for rapid deployment (days vs. months) and serves hospitals and health systems in the US and internationally.

ASCEND Cardiovascular is a specialized cardiovascular IT solutions provider headquartered in Springfield, Illinois. Founded in 1995, the company develops enterprise-grade structured reporting and workflow software designed exclusively for cardiology departments and health systems. The ASCEND CV portfolio delivers multimodality structured reporting capabilities that integrate diagnostic, procedural, and reporting workflows into a unified cardiovascular ecosystem. Core offerings include ASCEND CV (multimodality reporting software), ASCEND InView (zero-footprint DICOM viewer), Gen3Echo (AI-driven echocardiography reporting), ASCEND Analytics (open-schema data warehouse), and Catalyst LIVE (telepresence collaboration platform). The company provides vendor-agnostic solutions with device interfaces, clinical decision support, and implementation services. ASCEND serves leading North American health systems and hospitals, with specialized solutions for pediatric cardiology, congenital heart disease, and non-invasive cardiac imaging. The platform integrates seamlessly with major EHR/HIS systems and medical device manufacturers including Epic, Cerner, GE Healthcare, Philips, and AGFA Healthcare.

ChatRx is an FDA-approved, AI-powered asynchronous telemedicine platform specializing in diagnosis and treatment of 39 common acute infections. The platform combines proprietary AI-assisted symptom assessment with physician review and oversight to deliver care 24/7 without requiring video appointments or scheduled consultations. Available in Indiana, Illinois, and Michigan, ChatRx addresses healthcare access gaps for uninsured patients, rural communities, shift workers, and others facing barriers to traditional urgent care. The service operates on a flat-fee model ($25 per consultation, $10 for work/school notes) and provides treatment plans with prescriptions when medically appropriate. The platform achieves >90% diagnostic accuracy and includes integration with pharmacy networks for prescription delivery.

Vuzix Corporation is an optical technology company specializing in AI-powered smart glasses, waveguides, and augmented reality (AR) solutions for enterprise, industrial, medical, defense, security, and consumer markets. Founded in 1997 and headquartered in West Henrietta, New York, Vuzix designs and manufactures advanced wearable display systems including the M Series smart glasses, Vuzix Blade, Vuzix Shield, and Z100. The company provides waveguide optics, software solutions (including Mobilium logistics mobility software), and engineering services. With global operations in Rochester NY, Oxford UK, and Tokyo Japan, Vuzix serves multiple verticals through direct sales, resellers, and strategic partnerships. The company is ISO 9001:2015 certified and has over 25 years of experience in optical display solutions, positioning smart glasses as transformative tools for frontline workforce applications including telemedicine, remote assistance, warehouse operations, and healthcare delivery.

Eko Health is a digital health company specializing in AI-powered cardiac and pulmonary disease detection and monitoring. The company manufactures FDA-cleared digital stethoscopes and ECG devices that combine high-fidelity audio capture with real-time artificial intelligence algorithms to detect heart murmurs, atrial fibrillation, and reduced ejection fraction. Eko's product ecosystem includes the CORE 500™ Digital Stethoscope with advanced audio processing and noise cancellation, the CORE™ Digital Stethoscope (co-branded with 3M as Littmann® CORE), and the SENSORA® platform for health system integration. The company also offers Eko AI Analysis software for clinical decision support and Eko Telehealth for virtual exam capabilities, deployed in over 800 U.S. hospitals. With more than 700,000 devices sold globally, Eko operates the largest connected digital stethoscope network. The platform is clinically validated across 70+ peer-reviewed publications and holds 9 FDA clearances, with CMS reimbursement established for hospital-based outpatient cardiac screening.

Amalgam Rx is a regulated digital health company specializing in Software as a Medical Device (SaMD) development. Founded in 2016 and based in Wilmington, Delaware, the company develops AI-powered, modular SaaS platforms that integrate seamlessly with electronic health records (EHR) to enhance clinical decision-making across chronic care ecosystems. The company's Medical-Grade AI™ technology supports patient identification for clinical trials, clinical decision support, digital therapeutics (DTx), caregiver engagement, and wearable device integration. Amalgam Rx's platform has facilitated over 70 million clinical decisions and currently supports nearly 10 million patients across four continents with regulatory clearance. The company partners with life sciences organizations, health plans, and healthcare providers to deliver point-of-care solutions including care guidelines, financial assistance programs, and companion products. With demonstrated FDA expertise and Manufacturer of Record (MOR) designation, Amalgam Rx emphasizes regulatory compliance, quality management systems, and global scalability across multiple markets.

IONIC Health is a health-tech company specializing in automation, integration, and remote operation technologies for diagnostic medicine, particularly medical imaging. Founded in 2019 with headquarters in São José dos Campos, Brazil, and offices in Cleveland, Ohio and Portugal, IONIC Health serves over 90 B2B clients globally, including major diagnostic centers and hospital networks. The company provides comprehensive software and digital solutions designed to improve efficiency, safety, and accessibility in diagnostic imaging workflows. Key offerings include remote teleoperation platforms for imaging devices (MRI, CT, ultrasound), real-time equipment monitoring and analytics, AI-powered structured radiology reporting with speech recognition, and end-to-end integration solutions. IONIC Health leverages advanced technologies including artificial intelligence, machine learning, big data analytics, and voice recognition to enable remote scanning, automated workflows, and intelligent decision support. With CE Mark approval and ISO/IEC 27001 certification, IONIC Health has demonstrated measurable impact: over 1 million exams facilitated, 1 million+ medical reports issued, 300+ devices under teleoperation, and documented customer savings exceeding $20 million. The company serves a diverse network of over 2,500 physicians and continues expanding across Latin America, Europe, and North America.

YIWEI Medical Technology (Dr. Brain) is an AI-powered diagnostic platform specializing in central nervous system (CNS) disease detection and brain health management. Founded in 2017 in Shenzhen, the company leverages a comprehensive Chinese brain imaging database, cloud computing, and advanced AI algorithms to deliver intelligent imaging analysis and diagnostic support across multiple neurological conditions including Alzheimer's disease, mild cognitive impairment, Parkinson's disease, stroke, brain tumors, and autism spectrum disorders. The platform comprises four primary solutions: Dr. BrainCloud (intelligent imaging diagnostic platform for CNS disease assessment), Dr. Brain Tele (cloud-based tele-imaging platform supporting remote consultation and expert review across primary care facilities), Dr. Brain Pharm (neuropharmacological efficacy evaluation system for clinical drug development and R&D), and Dr. Brain Health (comprehensive brain health management services including AI-based whole-brain examination, disease prevention, VR-based cognitive rehabilitation training, and patient counseling). The company integrates quantitative structural brain analysis, personalized VR-based cognitive assessment using eye-tracking technology, and immersive rehabilitation training protocols to improve diagnostic accuracy and enable early intervention.

HealthArc is a comprehensive digital health platform specializing in remote patient monitoring (RPM), chronic care management (CCM), and care coordination software for healthcare providers. The platform integrates with over 40 compatible medical devices (blood pressure monitors, glucometers, pulse oximeters, weight scales, spirometers, continuous glucose monitors, thermometers, and medication adherence trackers) to enable real-time vital sign monitoring and patient data collection. HealthArc's unified care platform features AI-driven clinical pathways, automated workflow management, and intelligent patient communication via SMS and phone escalation. The software supports multiple CMS-compliant care programs including Remote Patient Monitoring, Chronic Care Management, Principal Care Management, Remote Therapeutic Monitoring, Transitional Care Management, Medication Therapy Management, Behavioral Health Integration, and Advanced Primary Care Management. The platform automates billing documentation and claims submission across these programs, integrates with existing EHR systems, and includes specialized clinical support services with enrollment specialists, RNs, LPNs, and medical assistants. HealthArc serves hospitals, primary care practices, virtual care delivery companies, and managed healthcare organizations, with current deployment across 40+ states serving 750+ providers and 65,000+ patients. The company prioritizes HIPAA compliance, SOC2 certification, and FDA-approved device integration.

PathPresenter is an enterprise-grade digital pathology image management and workflow platform founded in 2017 by Dr. Rajendra Singh, a dermatopathologist and digital pathology pioneer. The platform serves pathologists and medical institutions with FDA 510(k)-cleared and CE-IVDR certified clinical viewers for primary diagnosis and consultations. PathPresenter offers comprehensive modules including clinical care, enterprise education, biorepository management for research data, and remote consultation capabilities via ConsultConnect. The system emphasizes vendor-agnostic interoperability, supporting any scanner, storage platform, laboratory information system (LIS), and third-party AI models. Key features include optimized pathologist workflows, voice control integration, powerful slide administration, and seamless integration across institutional systems. With over 50,000 users across 172 countries and adoption by more than 50 top-tier hospitals, laboratories, and pharmaceutical companies, PathPresenter combines clinical performance with AI readiness, enterprise integration, and education leadership. The platform powers the College of American Pathologists' AI Studio, enabling testing of cutting-edge AI tools in realistic scenarios with whole slide images.

DrKumo is a Service-Disabled Veteran-owned digital health technology platform specializing in Remote Patient Monitoring (RPM) and chronic care management. The company delivers AI/ML-driven solutions that enable real-time health data transmission from patients' homes to clinical care teams, facilitating proactive interventions and early risk detection. DrKumo's platform integrates wireless medical sensors, mobile data acquisition, and intelligent cloud services to support evidence-based Disease Management Protocols for chronic conditions including diabetes, hypertension, COPD, and heart failure. The platform operates on military-grade cybersecurity infrastructure meeting HIPAA, FIPS, and NIST standards. DrKumo provides turnkey deployment with no upfront cost to providers and focuses on expanding healthcare access to rural and underserved communities, including Native American populations and veterans. The solution is designed to reduce hospital readmissions, improve patient satisfaction, increase provider reimbursement, and streamline administrative workflows across private practices, FQHCs, RHCs, and health systems.

EBM Technologies is a leading medical IT solutions provider specializing in Picture Archiving and Communication Systems (PACS), Electronic Medical Records (EMR), and Personal Health Records (PHR). Founded in 1988 in Taiwan, the company serves over 3,500 hospitals across Asia, North America, and the Middle East. EBM's product portfolio includes Enterprise PACS systems (SoliPACS®, Pangea® suite for Radiology/Dental/Mammography), mobile PACS applications (MobiPACS®), telemedicine platforms, and eHealth solutions. The company emphasizes interoperability, allowing integration across diverse healthcare infrastructure, and has shifted focus toward mobile medical applications and AI-integrated diagnostic solutions. With 150 employees, EBM delivers cost-effective, scalable, and customizable software platforms designed for efficient medical data management and enhanced patient care delivery.

Alliance Tech Medical manufactures and distributes a comprehensive line of respiratory disease management products for hospitals, surgery centers, physician offices, clinics, home care, and pharmacies. Their portfolio includes spirometers (MIR, ERT SpiroSphere, Micro Direct models), peak flow meters, inhalation training devices (In-Check DIAL, Trainhaler, AIM), nebulizers (PARI, SALTER), pulmonary function filters, CPAP cleaning systems (Lumin), respiratory muscle trainers (The Breather), and high-level disinfectants (Revital-Ox RESERT). They also distribute products from Clement Clarke International, Nasiff, and Cetylite Industries. Alliance Tech Medical offers OEM customization and branding services for medical devices, with a focus on affordable, practical solutions for respiratory care adherence and compliance management.

EyeQue Corporation is a FDA-registered health technology company specializing in smartphone-powered at-home vision testing solutions. The company develops clinically validated devices and AI-based applications that enable users to measure visual acuity, pupillary distance, and refractive error from home, facilitating prescription updates and vision tracking over time. Primary products include VERAI (complete AI vision solution), Insight Lite (pocket-sized screening device), PDCheck/PDCheckAR (pupillary distance measurement), myReaderNumber (reading glass prescription), Rx Renewal (prescription renewal service), and Try-On Glasses (virtual frame fitting). EyeQue's platform supports integration with eye care professionals for telemedicine consultations, interim monitoring, and online glasses purchasing. The solution addresses accessibility gaps for rural populations and patients with mobility constraints, with over 100,000 satisfied customers and clinical endorsement from optometrists.

Mindset Medical is a digital health technology company that delivers an intelligent virtual health platform enabling intake, patient assessments, triage, and virtual exams through smartphone-based contactless video vital sign measurement. The platform uses patented remote photoplethysmography (rPPG) technology to transform standard device cameras into non-contact vital sign sensors, measuring heart rate, respiratory rate, and other physiological parameters without requiring traditional measurement devices or wearables. The solution includes real-time remote patient monitoring, precision health analytics, and API integration capabilities for seamless deployment across digital health ecosystems. Core features include edge-processing for privacy (video analysis occurs on-device with no transmission), end-to-end encryption, and FDA-cleared respiratory rate measurement functionality. Ideal for telehealth platforms, chronic disease management, post-acute care coordination, and integrated care delivery requiring continuous remote patient monitoring without hardware burden.

JEDMED Instrument Company is a 100% employee-owned medical device manufacturer founded in 1978 and based in St. Louis, Missouri. The company specializes in high-quality surgical instruments and visualization equipment serving ENT, ophthalmology, dental, audiology, and telemedicine specialties. JEDMED offers a comprehensive portfolio including German-crafted surgical instruments, endoscopic video systems, examination and surgical chairs, microscopes, and specialized equipment such as the FDA-approved OMNISteth™ digital stethoscope for telemedicine applications. The company's product range encompasses endoscopic visualization systems, otoscopy equipment, stroboscopy systems, portable video systems, and exam room furniture. With approximately 35 employees, JEDMED maintains a strong commitment to customer satisfaction and professional support, distributing products through authorized partners including Melling Medical for federal healthcare systems. The company's offerings are particularly valued in clinical settings requiring precision visualization, diagnostic support, and ergonomic examination infrastructure.

Eyoto Group Limited manufactures Aetheia, a fully remote, automation-powered 4K digital slit lamp system designed for tele-optometry and remote eye examinations. The platform enables optometrists and ophthalmologists to deliver expert eye care from any location without patient travel, addressing clinician shortages and enabling clinic expansion across multiple sites. Aetheia features 120° arm rotation, 4K imaging with 25x zoom, and integrated automation capabilities (Auto-Optometry™ and Auto-Assist™) to streamline exam workflows. The system supports both remote control operation by licensed clinicians and fully autonomous examination modes, significantly increasing patient throughput without requiring additional headcount. Installation is scalable to any clinic setting, with onsite training and post-sale support included. The company has secured major deployments, including a nationwide rollout across SpaMedica's hospital network in the UK (announced December 2025). The Aetheia platform targets ophthalmology services facing resource constraints and high-volume optometry clinics seeking to optimize operational efficiency while maintaining diagnostic precision.

Solaborate Inc. develops hellocare, an integrated end-to-end telehealth and virtual healthcare delivery platform combining software, hardware, and artificial intelligence. The platform serves hospitals, home care, and primary care settings, enabling clinicians to deliver remote patient care through multiple modalities: virtual patient observation (up to 16 rooms monitored simultaneously), telehealth consultations, remote patient monitoring (RPM), and digital clinic services. Core capabilities include real-time audio/video communication, secure messaging, EHR integration, dynamic workflow management, and AI-driven alerting for fall detection and patient behavior monitoring. The company supplies integrated telemedicine carts (mobile hardware and software solutions), remote examination kits that enable physicians to assess vital signs and conduct clinical examinations from patient homes, and communication tools linking clinicians, nurses, and healthcare teams. The platform processes continuous patient observation data, captures health metrics from connected medical devices, and uses edge-based AI algorithms to generate clinical alerts while maintaining patient privacy. Solaborate maintains HIPAA compliance, HITRUST certification, SOC 2 attestation (AICPA), and CE marking. The platform is used by major healthcare systems including Amwell, Northwell Health, and Swiss healthcare organizations. Intended for B2B deployment in hospital systems, urgent care, home health agencies, and telemedicine networks requiring turnkey virtual care delivery infrastructure.

Cloud DX Inc. is a Canadian healthcare technology company specializing in remote patient monitoring (RPM) hardware, software, and digital health services. The company develops the FDA-registered, Health Canada-licensed Connected Health™ platform, which enables comprehensive vital sign monitoring and clinical engagement for chronic disease management, post-surgical care, palliative care, and transitional care. Cloud DX's integrated solution includes wireless vital sign devices (blood pressure monitors, weight scales, pulse oximeters), a clinician dashboard for real-time patient data review, a mobile app for patient engagement, and telemedicine capabilities powered by Zoom or Teladoc. The platform is currently deployed across 12 clinical use cases including COPD, heart failure, diabetes, post-surgical monitoring, and complex pediatric home care. Cloud DX operates a Virtual Care as a Platform (VCaaP) model with demonstrated patient satisfaction of 89–100% and peer-reviewed clinical evidence of improved outcomes, reduced ER visits, and decreased hospital admissions.

Aerotel Medical Systems is a global provider of remote patient monitoring and telemedicine solutions specializing in 12-lead ECG cardiac monitoring. The company manufactures portable, user-friendly ECG devices combined with cloud-based call center software and transtelephonic transmission capabilities for real-time patient data transfer via Internet, cellular, or telephone networks. Aerotel's product portfolio includes the HeartView 12L (professional handheld 12-lead ECG), HeartView P12/8i (Bluetooth-enabled personal ECG recorder), and HeartView P12/8 Mobile (home monitoring device with cellular modem and voice assistance). The company serves ambulance services, hospitals, telemedicine providers, and home monitoring programs globally. Aerotel's HeartView P12/8 has demonstrated clinical efficacy in published peer-reviewed research showing reduced in-hospital mortality when deployed by ambulance services. The company has successfully completed large-scale national projects, including equipping Hungary's national ambulance service (OMSZ) with ECG monitoring capabilities. Products incorporate voice-guided protocols to enable non-medical personnel to obtain hospital-grade ECG recordings. The company emphasizes one-stop integration support from solution design through implementation and ongoing operations. Founded in 1998, Aerotel maintains global headquarters in Holon, Israel, with international distribution through medical device distributors and service partners.

Buoy Health is an AI-powered digital health platform that provides symptom assessment, clinical decision support, and care navigation for consumers. The platform combines machine learning algorithms with clinician-reviewed medical content to help users identify potential health conditions based on self-reported symptoms and receive personalized guidance on appropriate care pathways. Founded by physicians and data scientists at Harvard Innovation Labs, Buoy integrates artificial intelligence-driven triage with expert-curated health information, enabling users to make informed decisions about seeking professional medical care. The company serves individuals seeking accessible, evidence-based health guidance and care coordination outside traditional clinical settings.

GlobalMed Holdings is a leading virtual health software and hardware platform company delivering enterprise telemedicine solutions for 20+ years. The company provides eNcounter®, a comprehensive all-in-one virtual care platform supporting 55+ clinical modalities with multi-modal device integration, AI-powered triage, and true EHR/EMR interoperability. GlobalMed's hardware ecosystem includes FDA-cleared diagnostic devices—TotalExam® 3.2 Camera for high-definition remote examinations, TotalECG® for cardiac monitoring, TotalVitals® for continuous vital signs capture, and ClearProbe® ultrasound system—enabling comprehensive head-to-toe remote physical exams with diagnostic-quality imaging and real-time data streaming. The company also manufactures portable clinical delivery stations (ClinicalAccess® Pro Connect, Transportable Exam Backpack) certified to ISO 13485 for hospital-grade care in austere, remote, and emergency environments. Additional offerings include GlobalMed Wellness employee mental health apps (Moodhacker®, Love Every Day®, Family Huddle®) developed with NIH grant funding. The platform is deployed across federal agencies (DoD, VA, DHS, Department of Justice), rural health systems, correctional facilities, large health systems, and international markets across 60+ countries, supporting 100 million+ virtual healthcare visits. Certifications include SOC 2 Type II, HIPAA compliance, FDA 510(k) clearances for medical devices, ISO 13485, and Authority to Operate (ATO) on DoD networks.

Smartsound Corporation is a Seoul-based medical technology company specializing in AI-powered sound-based diagnostic solutions. Founded in 2011, the company has developed proprietary edge artificial intelligence technology that analyzes heart and lung sounds for disease diagnosis. Since 2021, Smartsound has collaborated with 12 leading Korean university hospitals to collect and analyze clinical data, securing AI diagnostic technologies capable of identifying 5 types of lung diseases and 5 types of heart diseases. The company offers a comprehensive portfolio of AI-enabled stethoscope products—including the SKEEPER R1 (hospital-grade), SKEEPER H1 (telemedicine/homecare), SKEEPER P1 (wearable patch for continuous monitoring), SM-300 (non-face-to-face telemedicine), and WITH A PET (veterinary cardiac assessment)—all featuring hardware-embedded AI, cloud data storage, Bluetooth connectivity, and telemedicine integration. Products support diagnosis, monitoring, and early detection of respiratory infections and cardiac conditions across clinical, home healthcare, and veterinary markets.

Remote Patient Devices, LLC is a US-based remote patient monitoring (RPM) provider serving medical practices, healthcare facilities, and chronic disease management programs. The company develops and operates a cloud-based RPM platform enabling patients to transmit vital signs—blood pressure, glucose levels, and weight—from home or office settings for real-time clinical review. The platform integrates with existing EHR systems, supports iOS and Android mobile applications, and includes automated time tracking, customizable clinical alerts, and EMR interoperability. Remote Patient Devices serves solo practices, group practices, and larger healthcare systems seeking to expand preventive and chronic care management outside traditional clinical settings. The company handles end-to-end RPM implementation including patient eligibility verification, care plan development, medical billing and coding, and compliance with current healthcare regulations (MIPS quality measures, value-based care models). The platform emphasizes patient engagement, clinical actionability of real-time data, and revenue optimization through accurate remote patient monitoring billing. Core use cases include hypertension management, diabetes monitoring, and post-acute care transitions. Remote Patient Devices markets RPM as a tool for reducing hospital readmissions, improving MIPS scores, and generating $100,000–$150,000 annual revenue per 100 monitored patients for practices. The company provides practitioner training, ongoing clinical support, and billing assistance to ensure sustainable adoption.

NeuroVision Imaging, Inc. is a digital health and diagnostic imaging company focused on neurology and cognitive health. The company operates two primary business lines: BrainHealth, a comprehensive telehealth platform for cognitive neurology that addresses diagnostic wait times through patient screening, triage, and managed care workflows; and Afina, a proprietary retinal imaging platform with cloud-based AI software designed to identify amyloid signatures in the retina as indicators of Alzheimer's disease and Cerebral Amyloid Angiopathy (CAA). BrainHealth offers neurologist-designed preventative neurology strategies, brain health education (covering nutrition, sleep, exercise, and mindfulness), lifestyle change coaching via telehealth, APOE genetic testing, biomarker testing, and clinical trial information. Afina leverages advanced imaging and AI analytics to support prediction of CAA and amyloid-related imaging abnormalities (ARIA), the significant side effect associated with emerging Alzheimer's treatments. The platform combines diagnostic innovation with clinical validation through ongoing groundbreaking studies. NeuroVision targets healthcare providers, health systems, and patients seeking accessible, evidence-based neurology diagnostics and preventative care at scale.

Virtual Radiologic Corporation (vRad) is a distributed radiology services provider delivering 24/7 teleradiology coverage, AI-assisted diagnostic support, and integrated radiology platform solutions. Founded in 2001, vRad operates as a remote radiology network serving 140+ communities with a focus on subspecialized services, particularly breast imaging including telemammography screening, diagnostics, and compliance support. The company has served over 115.9 million patients. vRad's core offerings include: (1) Teleradiology Services—remote radiology interpretation with rapid turnaround for critical patients; (2) vRad Platform—a unified radiology information system (RIS) and PACS ecosystem designed to reduce administrative burden and integrate disconnected radiology workflows; and (3) Radiologist staffing and career opportunities with flexible scheduling. The platform incorporates 25+ proprietary AI models to enhance diagnostic speed and accuracy, achieving 99.87% accuracy with 88% fewer errors compared to published benchmarks. The company employs over 140 subspecialist radiologists and maintains focus on early breast cancer detection through telemammography services. vRad's technology stack is built by radiologists and engineers to optimize the radiology workflow and practitioner experience. The platform includes integrated reporting, quality assurance tools, and subspecialty decision-support capabilities. vRad serves hospitals, imaging centers, and multi-specialty practices seeking outsourced teleradiology coverage or platform modernization. High radiologist satisfaction metrics (98% would remain with vRad; 96% proud to be associated) reflect competitive compensation and schedule flexibility. The company operates nationwide with centralized remote reading infrastructure.

Remmie Health manufactures FDA-registered, portable digital otoscopes designed for home and telehealth-enabled ear, nose, and throat (ENT) examination and remote sharing with healthcare providers. The company's core product line includes the Remmie 3 and Remmie 4, intelligent otoscope cameras with high-definition (720p) imaging, wireless connectivity, real-time video streaming capabilities, and cloud-enabled mobile applications for iOS and Android devices. Remmie devices feature 3.9mm diameter lenses, adjustable brightness (5 levels), waterproof design, 2.4GHz Wi-Fi connectivity, and battery life supporting extended use. All devices ship with disposable specula, cleaning pads, charging accessories, and setup guidance. The Remmie App provides AI-guided image capture, local recording and saving of images and video, and live streaming to clinicians for remote diagnosis and intervention without requiring an internet connection for basic operation. The company targets parents, caregivers, and patients managing common ear and upper respiratory conditions (otitis media, otitis externa, sinusitis, pharyngitis, tonsillitis, strep throat, pink eye) while reducing costly emergency room and urgent care visits. Remmie devices are FDA Class 1 registered, CE marked, and cleared by Health Canada and Australian TGA. The company explicitly clarifies that Remmie devices are examination tools only and does not provide diagnostic, prescription, or telehealth services; users must consult independent healthcare providers for clinical care. Regulatory compliance and clinical validation are central to the company's positioning.

Heru, Inc. is an ophthalmology and eye care technology company founded on clinical research from the University of Miami's Bascom Palmer Eye Institute, the nation's leading eye hospital. The company develops wearable headset-based vision testing systems and digital eye care platforms, with a primary focus on visual field testing, glaucoma screening, and tele-optometry solutions. Heru's flagship product, Heru Prime, is a next-generation multimodal platform designed to standardize patient pretesting and elevate clinical workflows. The company also offers EyeStream™ technology, a pretesting solution that reduces manual variability in patient assessment. Heru's systems are designed for optometry practices, ophthalmology clinics, and telehealth platforms seeking to improve patient throughput and diagnostic accuracy. The company has received recognition as a CES 2023 Innovation Awards Honoree in the Virtual and Augmented Reality category for two consecutive years, validating the clinical efficacy and innovation of its wearable headset approach. Heru conducts clinical validation studies comparing its wearable-based visual field measurements against standard automated perimetry, demonstrating comparable accuracy in a more accessible format. The platform supports tele-optometry strategies, allowing remote eye care delivery with standardized pretesting protocols.

Actuvi is an award-winning remote therapeutic monitoring (RTM) and digital health delivery platform designed for clinical practices and healthcare organizations. The platform enables providers to deliver preventative and value-based care by integrating multiple apps, connected medical devices, and clinical assessments into a unified system. Actuvi aggregates patient physiological data, assessments, and interactions in one interface, eliminating traditional data silos. The platform includes a HIPAA-compliant web application, patient-facing mobile app (FDA-registered Software-as-Medical Device), and telehealth capabilities. Core features encompass remote patient monitoring, remote therapeutic monitoring (RTM), advanced primary care management, patient-practitioner messaging, PREMs and PROMs, eCOA/EDC for clinical trials, and custom assessment creation. The system integrates with EHRs, EMRs, Apple Health, Google Fit, and medical devices. Automation tracks, organizes, and assigns care activities to appropriate CPT codes for billing optimization. Actuvi serves diverse specialties including cardiology, concierge clinics, pain management, primary care, mental health, OB-GYN, oncology, orthopedic clinics, FQHCs, RHCs, and ABA clinics. The platform supports in-office, at-home, and rehabilitation care settings. Services include ongoing support, weekly program reporting, staff training, custom program configuration, and automated clinical notifications. The company has received multiple awards for remote therapeutic software and digital care solutions, and is trusted by major healthcare organizations.

Contact Health Inc operates a cloud-based remote patient monitoring (RPM) and virtual care engagement platform designed for healthcare providers to remotely monitor and interact with diverse patient populations. The platform addresses chronic disease management, behavioral and physical therapy, post-discharge care programs, and senior/disabled populations. The company's integrated solution comprises three core components: the Contact Health Tablet (patient-facing device with two-way video, biometric data transmission, health education, medication/appointment reminders, and secure messaging); the Contact Health Portal (provider-facing command center with risk stratification, triage tracking, vital sign graphing, medication adherence monitoring, non-responder tracking, and outcome reporting); and Contact Health Vitals (an array of medical devices including weight scales, blood pressure cuffs, pulse oximeters, glucose meters, and spirometers for automated biometric capture). The platform enables providers to capture vital signs data, interpret alerts through automated triage logic, intervene via video consultations, and monitor patient compliance with care plans. Key features include data analytics and trend reporting, population work lists, care calendars, and logistics/program support services. The company markets the solution to healthcare systems, accountable care organizations, behavioral health providers, and post-acute care settings seeking to improve remote monitoring capabilities and reduce hospital readmissions. The address on file matches the website, and the company can be reached at the provided contact information.

LetsGetChecked Inc. is a direct-to-consumer and B2B healthcare company specializing in at-home health testing, telehealth consultations, and pharmacy services. The company manufactures and distributes at-home sample collection kits analyzed by its own CLIA-certified, CAP-accredited laboratory. Services include comprehensive health screening panels (cancer screening, women's health, men's health, infectious disease, biometric screening, and gap-in-care solutions), board-certified telehealth consultations via secure messaging, and affiliate pharmacy services for medication fulfillment and support. LetsGetChecked operates an integrated platform combining in-house manufacturing, laboratory analysis, clinical consultation, and pharmacy operations. The company serves both individual consumers and institutional clients including employers, health plans, health systems, and large organizations (Amazon, Denver Health, Humana, Berkshire Hathaway, University of Virginia, and others). Over 10 million kits have been used, with service delivery focused on accessibility, privacy, and convenience. The company is part of Fuze Health, a broader healthcare innovation platform. Regulatory compliance includes CLIA laboratory certification and CAP accreditation for clinical testing operations.

Athena GTX manufactures compact, wireless patient monitoring systems designed for field and emergency medical scenarios. The company specializes in portable vital sign monitoring technology that enables real-time connectivity between patients and healthcare providers across distances. Their product suite is engineered for deployment in challenging environments including emergency departments, EMS transport, tactical medicine, battlefield triage, mass casualty incidents, search and rescue operations, and telemedicine applications. The systems are manufactured in-house in Iowa using proprietary medical and communication technology. Athena GTX serves emergency medical services, military/tactical medicine, public safety agencies, border security, and hospital emergency departments. The company positions its solutions for scenarios requiring rapid patient assessment, multi-patient monitoring, and remote clinical decision support. Applications span civilian emergency response, disaster management, infectious disease containment, and specialized rescue operations.

WoundMatrix is a cloud-based mobile wound documentation and telehealth platform designed for secure capture, measurement, and upload of wound images and clinical data at the point of care. The solution comprises a mobile application (tablet-based) paired with a Health-Enabled Cloud environment for centralized image reading, data analytics, and outcome tracking. Core capabilities include objective wound measurement technology (validated against Johns Hopkins clinical studies to reduce measurement variability), real-time data collection and analytics, customizable data fields for organizational standardization, and powerful outcome tracking reports for identifying trends and improving patient care quality. The platform is HIPAA-compliant and 21 CFR Part 11 validated, supporting both standalone cloud deployment and EHR integration. WoundMatrix serves private sector, governmental, and educational healthcare organizations, particularly those managing community wound care programs. The company partners with major health IT providers (Insight Enterprises) and integrates with leading UK electronic patient record systems (Rio EPR). WoundMatrix holds UKCA marking for UK market deployment and is accredited with the Association of British HealthTech Industries (ABHI) and the Professional Record Standards Body (PRSB), positioning it for adoption across NHS community services. The platform emphasizes ease of use, scalability to any organization size, and clinician-centric mobile workflows for wound documentation and remote care coordination.

Perigon Health 360 is a digital enterprise health platform specializing in remote patient monitoring (RPM), remote therapeutic monitoring (RTM), and chronic care management (CCM) services. The company develops proprietary medication adherence platforms and WiFi-connected medication dispensing devices that track real-time compliance data and integrate with healthcare provider systems through open APIs. Perigon Health 360's flagship offering, Medesto, is an enterprise drug and therapy monitoring platform that consolidates RPM and RTM services into a single portal, enabling healthcare providers and independent pharmacies to pursue reimbursement for monitoring services. The platform connects medication dispensing devices, physiological monitoring devices, and reimbursement tracking to simplify pharmacy compliance workflows. The company operates Perigon Pharmacy 360, an in-house pharmacy service covering all 50 states with specialty drugs and mail-order retail medications. Core capabilities include secure digital health data ecosystems, patient portal functionality, mobile app integration (Medesto app), and real-time alerting and reminder systems. The platform addresses medication non-adherence through multi-modal notifications and patient engagement tools. Perigon Health 360 holds URAC accreditation and is ACHC-certified, indicating compliance with industry standards for telehealth and pharmacy operations. The company serves healthcare providers, independent pharmacies, and patients with chronic conditions requiring ongoing medication management and monitoring.

ForaCare Inc. is a healthcare technology company specializing in chronic disease management through integrated medical devices and telehealth software. The company designs and manufactures blood glucose monitors, blood pressure monitors, pulse oximeters, nebulizers, wireless weight scales, and Bluetooth thermometers for diabetes, hypertension, COPD, and chronic heart failure management. All devices connect via cellular or Bluetooth to the proprietary FORA® 24/7 HealthView Telehealth System, a HIPAA-compliant cloud platform that enables real-time remote patient monitoring and physician access to patient data. ForaCare also offers iFORA mobile applications available on iOS and Google Play for patient engagement and chronic disease self-management. The company manufactures and designs products with an emphasis on accuracy, ease of use, and clinical validation. Primary markets include remote patient monitoring programs for chronic disease management across diabetes care, hypertension management, respiratory care, and weight management. The FORA 24/7 HealthView System serves as the central integration hub connecting all wireless medical devices to a telehealth gateway for comprehensive remote monitoring. ForaCare operates with a global customer base and maintains design and manufacturing capabilities.

Hospicio La Paz is a leading hospice and palliative care provider in Puerto Rico, specializing in home-based end-of-life and comfort-focused medical services. The organization delivers comprehensive interdisciplinary care including physician oversight, nursing, medication management, respiratory therapy, and psychosocial support. Core service offerings include mechanical ventilation and BiPAP support (pioneering life-support equipment services with dedicated respiratory therapy staff), medication provision (5% copay or $5 minimum per medication), medical equipment and supplies, nutritional counseling, social work, spiritual care, and housekeeping assistance for activities of daily living. The company operates 24/7 physician and nursing availability. Telemedicine capability provides off-hours physician response to patient needs. Post-bereavement family support extends up to one year following patient death. Services are delivered in-home to emphasize comfort and dignity. The organization markets itself as a leader in palliative care services across Puerto Rico, with multiple operational locations. All care is designed as palliative comfort-focused rather than rehabilitative.

Healthcare MIT Services (HMS) is a medical technology company delivering AI-powered diagnostic imaging, intelligent patient monitoring, and connected care solutions. The company manufactures and distributes portable imaging systems, including low-dose fluoro-radiography and tabletop X-ray equipment designed for point-of-care, remote, and field deployment. Key product lines include contactless fall management and bedside monitoring systems utilizing AI-driven analysis without cameras or wearables; AI-enabled respiratory monitoring with noise-filtering capabilities; and clinical chemistry analyzers capable of running 16 tests in under 5 minutes with minimal blood samples (<90μL), ideal for remote and point-of-care settings. HMS also offers intelligent healthcare software solutions spanning smart ward and mobile nursing platforms, telehealth and remote care systems, and smart operating room integration. Medical supplies include certified PPE, mobile carts, and ready-to-deploy clinical kits. The company holds certifications including ISO 9001, ISO 13485, FDA clearance, EN 60601-1 medical device standard compliance, GMP, FCC, CUL, and CSA. HMS markets to hospitals, clinics, long-term care facilities, and field medical teams globally, with demonstrated presence at major medical conferences (HIMSS, RSNA, DMEA, AHCA/NCAL). The company emphasizes AI integration, radiation reduction, mobility, and safety across its product portfolio.

Escalon Medical Corp. (OTCQB: ESMC) is a publicly-traded medical device company specializing in ophthalmic diagnostics imaging and surgical solutions. Operating through its wholly-owned Sonomed Escalon subsidiary group, the company develops, manufactures, markets, and distributes a portfolio of ophthalmology products including ultrasound imaging systems, digital photography devices, image management platforms, and telemedicine solutions. The Sonomed Escalon brand consolidates products previously marketed under the Sonomed, Escalon Digital Solutions, Escalon, and Trek Medical brands. The company serves ophthalmology practices, surgical centers, and hospitals with diagnostic and imaging technologies. Escalon maintains corporate headquarters in Wayne, Pennsylvania, with operations located in Lake Success, New York; New Berlin, Wisconsin; and Stoneham, Massachusetts. The company pursues growth through development of new products, strategic partnerships, and acquisitions within the ophthalmic sector. As a medical device manufacturer, Escalon is subject to FDA regulation and operates under applicable quality and compliance standards for the medical device industry.

Thinklabs Medical manufactures digital stethoscopes designed for clinical auscultation and telemedicine integration. The company's flagship product, the Thinklabs One Digital Stethoscope, features 100x audio amplification with five precision filter options, enabling clinicians to isolate and enhance cardiac, pulmonary, and other body sounds. The device includes rechargeable battery technology (100–120 patient exams per charge), Bluetooth and wired connectivity to most headphones and telemedicine platforms, and integrates seamlessly with major EHR and telemedicine software including Zoom, Cisco WebEx, Teladoc, American Well, and other systems without requiring screen switching during patient consultation. The stethoscope is used across 50+ countries and seven continents in primary care, cardiology, pulmonology, nursing, education, critical care, emergency medicine, pediatrics, NICU, anesthesiology, hospice, research, veterinary, and government/military settings. Marketed as a device for both clinical diagnostics and enhanced hearing accessibility for audiologists and hard-of-hearing practitioners, Thinklabs stethoscopes are employed in hospitals, FQHCs, acute care facilities, clinical trials, school-based health programs, and workplace health initiatives. The company emphasizes precision audio engineering and clinical utility without proprietary ecosystems, enabling broad deployment across institutional and private practice settings.

Aventusoft, LLC is a Boca Raton, Florida-based medical technology company specializing in signal detection analysis and AI-driven digital health platforms since 2010. The company develops innovative solutions focused on cardiac monitoring, clinical decision support, and decentralized clinical research. Primary product lines include Hemotag, a non-invasive cardiac monitoring device paired with AI analytics to reduce reliance on invasive cardiac imaging and implantable devices; CarePear, a digital health platform connecting patients and physicians with US-based sub-specialists through AI-enabled telemedicine; and Trialogy, an AI-driven platform for decentralized clinical trials that streamlines life science research. Aventusoft has received recognition from the NIH (RADx Tech for Maternal Health Challenge), DARPA, American College of Cardiology (ACC Innovation Showcase Award 2021 and 2023), and multiple design and innovation awards. The company demonstrated 146% two-year revenue growth and ranked No. 112 on Inc. Magazine's 2023 Southeast Region fastest-growing private companies list. Products target cardiac care, maternal health, specialist access, and clinical research domains, with regulatory focus on maternal health applications and AI-driven diagnostics.

Nonagon Ltd. designs and distributes FDA-cleared telehealth device kits that enable patients to conduct multiple clinical physical exams remotely via smartphone. The Nonagon Care Kit is a portable, all-in-one diagnostic tool that includes a digital thermometer, stethoscope, pulse oximeter, and otoscope (video ear examination). Patients capture vital signs and visual findings, then securely transmit results to US-certified clinicians for virtual consultation. The platform supports up to nine distinct medical exam types, including temperature, skin photography, oxygen saturation, lung auscultation, cardiac auscultation, otoscopy, abdominal sounds, and throat visualization. Clinical applications span acute care (infections, fever, respiratory conditions including COVID-19, COPD, asthma, pneumonia), dermatology (rashes, cuts, bruises), and ENT (ear infections, sore throat, tonsillitis). Nonagon operates a subscription-based model: ConnectCare membership at $7.99/month provides ongoing result-sharing and clinical access; virtual care visits are priced at $39 (adult) and $49 (pediatric, ages 3–17). The Care Kit retails at $239.99 or $19.99 monthly. Device is FDA-cleared; regulatory clearance substantiates clinical accuracy claims. Target markets include direct-to-consumer telemedicine, family health monitoring, concierge practices, and direct-care clinics seeking to close diagnostic gaps in remote settings.